[ad_1] Brokerage firm Morgan Stanley on Thursday, March 13, projected a 17.5% upside on shares of newly listed Dr. Agarwal’s Health Care Ltd. after initiating coverage on the stock. The brokerage has an “overweight” rating on Dr. Agarwal’s with a price target of ₹502 per share. This is the first analyst rating the stock has […]
Stocks to Watch on February 17: BHEL, Samvardhana Motherson, RVNL, Glenmark Pharma and more – CNBC TV18
[ad_1] 1 / 14 BHEL | State-run engineering giant announced a significant contract win, securing an order worth ₹6,700 crore from Singareni Collieries Company (SCCL) to establish an 800 MW thermal power unit in Telangana. The contract, awarded on an Engineering, Procurement, and Construction (EPC) basis, covers the design, engineering, manufacturing, supply, erection, commissioning, and […]
Dr Agarwal’s Health Care raises ₹875.50 crore from anchor investors ahead of IPO – CNBC TV18
[ad_1] Eye-care chain Dr Agarwal’s Health Care has secured ₹875.50 crore from anchor investors just a day before its initial public offering (IPO) opens for public subscription on Wednesday, January 29. Company Value Change %Change In a regulatory filing on Tuesday, the company revealed that it had allocated 2,17,78,798 equity shares at ₹402 per share […]